Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment Market: A Significant Driver Propelling The Pharyngitis Treatment Market In 2025

The Pharyngitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Pharyngitis Treatment Market Size and Projected Growth Rate?
In recent times, there has been a consistent increase in the size of the pharyngitis treatment market. It is projected to expand from $2.27 billion in 2024 to $2.37 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. Factors such as a high rate of flu incidence, increasing prevalence of pharyngitis, heightened awareness about pharyngitis, improved healthcare accessibility, and a rise in disposable incomes have contributed to the growth observed in the historic period.

In the coming years, the market size for pharyngitis treatment is poised for robust growth. The market is projected to reach $2.99 billion by 2029, experiencing a compound annual growth rate (CAGR) of 6.0%. Factors contributing to this growth within the projected period include the adoption of rapid point-of-care tests, an increased demand for personalized medicine, the proliferation of antibiotic resistance, and a growing focus on hand hygiene. The period is also likely to witness key trends such as advancements in the research and development of therapies for pharyngitis, the rise of digital health technologies, and the integration of telehealth.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12937

What Are the Major Segments in the Pharyngitis Treatment Market?
The pharyngitis treatment market covered in this report is segmented -

1) By Drug Class: Beta Lactams, Macrolides, Cephalosporins, Fluoroquinolones, Tetracycline, Other Drug Classes
2) By Source of Infection: Viral, Bacterial
3) By Modes Of Delivery: Oral, Intravenous, Intramuscular, Other Modes Of Delivery
4) By End-Users: Hospitals, Homecare, Specialty Centers, Other End-Users

Subsegments:
1) By Beta Lactams: Penicillins, Amoxicillin, Ampicillin
2) By Macrolides: Erythromycin, Azithromycin, Clarithromycin
3) By Cephalosporins: Cefuroxime, Ceftriaxone, Cefdinir
4) By Fluoroquinolones: Ciprofloxacin, Levofloxacin, Moxifloxacin
5) By Tetracycline: Doxycycline, Minocycline, Tetracycline
6) By Other Drug Classes: Clindamycin, Sulfonamides, Carbapenems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp

What Are The Driving Pharyngitis Treatment Market Evolution?
The projected growth of the pharyngitis treatment market is expected to be driven by the escalating spread of strep throat. This contagious bacterial infection chiefly affects the throat and tonsils. Speedy and efficient treatment of strep throat using antibiotics plays a significant role in alleviating symptoms, averting complications, and lessening the risk of infecting others. Data from the Centers for Disease Control and Prevention in June 2022 showed that there are approximately 14,000 to 25,000 instances of invasive group A strep disease in the U.S each year. Moreover, strep diseases are responsible for about 5.2 million outpatient visits and 2.8 million antibiotic prescriptions each year. Thus, the growing spread of strep throat is propelling the pharyngitis treatment market. The surge in influenza cases is anticipated to fuel the expansion of the pharyngitis treatment market. Known commonly as the flu, influenza is a contagious respiratory disease triggered by influenza viruses. The primary application of pharyngitis treatment is to combat influenza and alleviate its symptoms, including inflammation or irritation. This treatment also aims to relieve allergies and prevent complications such as pneumonia and bronchitis. The European Centre for Disease Prevention and Control (ECDC) reported in July 2023 that during the 2022/2023 influenza season in the EU/EEA, the positivity rate stood at 42% in the 51st week of 2022 and hovered around 28% from the 5th to the 12th week of 2023. Hence, the burgeoning incidence is steering the growth of the pharyngitis treatment market.

Which Firms Dominate The Pharyngitis Treatment Market Segments?
Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

What Trends Are Expected to Dominate the Pharyngitis Treatment Market in the Next 5 Years?
Leading businesses in the pharyngitis treatment market are concentrating their efforts on the creation of novel products like oral monotherapy, with the aim of boosting patient adherence and supplying efficient, accessible treatment alternatives. Oral monotherapy is a method of treatment that involves the consumption of a single medication to target a specific ailment. It utilizes only one therapeutic agent, rather than a combination, to reach the desired treatment outcome. For instance, in December 2023, the FDA granted approval to the Switzerland-based pharmaceutical company Novartis AG for the use of Fabhalta (iptacopan), marking it as the premier oral monotherapy for adults diagnosed with paroxysmal nocturnal hemoglobinuria (PNH). This achievement, reached on [date], signifies considerable progress by introducing a new treatment that raises hemoglobin levels, therefore removing the requirement for blood transfusions.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report

Which Is The Largest Region In The Pharyngitis Treatment Market?
North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Pharyngitis Treatment Market?
2. What is the CAGR expected in the Pharyngitis Treatment Market?
3. What Are the Key Innovations Transforming the Pharyngitis Treatment Industry?
4. Which Region Is Leading the Pharyngitis Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.